Covid19NCT04529447
Response of Korean Medicine Hospital to COVID-19
An observational study of Covid19, run by Jaseng Hospital of Korean Medicine at 1 site in South Korea.
Trial summary
The objectives of this study are to report the response strategy to prevent COVID-19 spread implemented at a Korean medicine hospital, and the satisfaction survey results regarding its preventive measures. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Covid19
- What is being tested?
- Survey
- How many people
- 485 participants
- Where
- 1 siteSouth Korea
- Study dates
- 10 Jun 2020to 10 Aug 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Inpatients hospitalized and outpatients visiting Jaseng Hospital of Korean medicine during March 23-25, 2020
Who may be able to join
- Inpatients hospitalized at Jaseng Hospital of Korean medicine during March 23-25, 2020
- Outpatients visiting Jaseng Hospital of Korean medicine during March 23-25, 2020
Who cannot join
- Visitors visiting Jaseng Hospital of Korean medicine during March 23-25, 2020 for purposes other than treatment
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Hospital Operational Response Strategy and Experience During the COVID-19 Pandemic in a Spine-specialty Korean Medicine Training Hospital
The objectives of this study are to report the response strategy to prevent COVID-19 spread implemented at a Korean medicine hospital, and the satisfaction survey results regarding its preventive measures.
Read the detailed description
The objectives of this study are (1) to report the response strategy to prevent COVID-19 spread implemented at a Korean medicine hospital situated in Seoul, Korea, (2) to describe patient visit trends compared to the number of confirmed COVID-19 cases during the COVID-19 peak in February - April 2020, and (3) to provide results of a satisfaction survey regarding its preventive measures.
- Conditions
- Covid19
- Being tested
- Survey
- Medical subject headings
- COVID-19
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyOther
The patient satisfaction survey consisted of 8 items, including 7 Likert scale questions and 1 multiple choice question.
| Study group | Role | What they receive |
|---|---|---|
| Patient satisfaction survey | Jaseng Hospital of Korean medicine conducted a pen and paper survey on patient satisfaction with regard to its COVID-19 response in inpatients hospitalized and outpatients visiting during March 23-25, 2020. Receives: Other: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Satisfactory service regarding hospital response to COVID-19
Multiple choice question on satisfactory service regarding hospital response to COVID-19, if any
Measured: Baseline (time of current visit)
Secondary outcomes (7)
Feelings of apprehension regarding hospital visits
Likert scale question on level of feelings of apprehension before hospital visits due to COVID-19
Measured: Baseline (time of current visit)
Medical staff wearing of facial masks and hand hygiene
Likert scale question on level of maintenance of wearing of facial masks and hand hygiene in medical staff
Measured: Baseline (time of current visit)
Cleanliness and sterilization of hospital facilities
Likert scale question on level of cleanliness and sterilization of hospital facilities with regard to COVID-19 spread prevention
Measured: Baseline (time of current visit)
Convenience and accessibility of hand sanitizers
Likert scale question on level of convenience and accessibility of hand sanitizers
Measured: Baseline (time of current visit)
Helpfulness and readability of posters and stand-up banners
Likert scale question on level of helpfulness and readability of posters and stand-up banners with COVID-19 information in the hospital
Measured: Baseline (time of current visit)
Satisfaction with hospital safety measures for COVID-19
Likert scale question on level of satisfaction with hospital safety measures for COVID-19
Measured: Baseline (time of current visit)
Recommendation of hospital to friends and family
Likert scale question on level of recommendation of this hospital to friends and family concerned with visiting hospitals due to COVID-19
Measured: Baseline (time of current visit)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Aug 2020
- Study start10 Jun 2020
- Primary completion10 Aug 2020
- Study completion10 Aug 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Covid19Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Retrospective
- Enrolment
- 485 participants (actual)
Sponsor and investigators
- Lead sponsor
- Jaseng Hospital of Korean Medicine
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Jinho Lee, KMD, Ph.D., Study director, Jaseng Hospital of Korean Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04529447
- Sponsor's protocol ID
- JMA-CT-2020-01
- Status last verified
- Jul 2022
- First submitted
- 26 Aug 2020
- Last updated
- 22 Jul 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Jul 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Hospital Operational Response Strategy and Experience During the COVID-19 Pandemic in a Spine-specialty Korean Medicine Training Hospital
- ClinicalTrials.gov ID
- NCT04529447
- Acronym / sponsor ID
- JMA-CT-2020-01
- Conditions
- Covid19
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 485 participants (actual)
- Lead sponsor
- Jaseng Hospital of Korean MedicineUniversity, hospital or other
- Study start
- 10 Jun 2020 (actual)
- Primary completion
- 10 Aug 2020 (actual)
- Study completion
- 10 Aug 2020 (actual)
- First posted
- 27 Aug 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objectives of this study are to report the response strategy to prevent COVID-19 spread implemented at a Korean medicine hospital, and the satisfaction survey results regarding its preventive measures.
Detailed description
The objectives of this study are (1) to report the response strategy to prevent COVID-19 spread implemented at a Korean medicine hospital situated in Seoul, Korea, (2) to describe patient visit trends compared to the number of confirmed COVID-19 cases during the COVID-19 peak in February - April 2020, and (3) to provide results of a satisfaction survey regarding its preventive measures.
Study design
- Observational model
- Other
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patient satisfaction survey | – | Other: SurveyJaseng Hospital of Korean medicine conducted a pen and paper survey on patient satisfaction with regard to its COVID-19 response in inpatients hospitalized and outpatients visiting during March 23-25, 2020. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Inpatients hospitalized and outpatients visiting Jaseng Hospital of Korean medicine during March 23-25, 2020
Key inclusion criteria (2 listed)
- Inpatients hospitalized at Jaseng Hospital of Korean medicine during March 23-25, 2020
- Outpatients visiting Jaseng Hospital of Korean medicine during March 23-25, 2020
Key exclusion criteria (1 listed)
- Visitors visiting Jaseng Hospital of Korean medicine during March 23-25, 2020 for purposes other than treatment
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurveyThe patient satisfaction survey consisted of 8 items, including 7 Likert scale questions and 1 multiple choice question. | Other | Patient satisfaction survey |
Primary outcome
Satisfactory service regarding hospital response to COVID-19
Time frame: Baseline (time of current visit)
Multiple choice question on satisfactory service regarding hospital response to COVID-19, if any
7 secondary outcomes
Feelings of apprehension regarding hospital visits
Time frame: Baseline (time of current visit)
Medical staff wearing of facial masks and hand hygiene
Time frame: Baseline (time of current visit)
Cleanliness and sterilization of hospital facilities
Time frame: Baseline (time of current visit)
Convenience and accessibility of hand sanitizers
Time frame: Baseline (time of current visit)
Helpfulness and readability of posters and stand-up banners
Time frame: Baseline (time of current visit)
Satisfaction with hospital safety measures for COVID-19
Time frame: Baseline (time of current visit)
Recommendation of hospital to friends and family
Time frame: Baseline (time of current visit)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Jul 2022.
- Individual participant dataSharing planned: No
Related trials for Covid19
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Active, not recruiting
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
Mental Health Issue, Mental Health Disorder
Recruiting
Home-Based Exercise Tele-Rehabilitation After COVID-19
Post SARS-CoV2 (COVID-19)
Not yet recruitingPhase 1
A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine
COVID -19
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jinho Lee, KMD, Ph.D. study director
Jaseng Hospital of Korean Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Covid19, run by Jaseng Hospital of Korean Medicine at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Satisfactory service regarding hospital response to COVID-19 (time frame: Baseline (time of current visit)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2022.